Extraction of triterpenoid compounds from Ganoderma Lucidum spore powder through a dual-mode sonication process

Shuang-Fei Shen,Li-Fang Zhu,Zijing Wu,Guangkun Wang,Zeeshan Ahmad,Ming-Wei Chang
DOI: https://doi.org/10.1080/03639045.2020.1764022
IF: 3.727
2020-05-13
Drug Development and Industrial Pharmacy
Abstract:Development of drug products from natural sources enable advantageous treatment and therapy options. Bioactive compounds in <i>Ganoderma lucidum</i> spore powder (GLSP) are known for vast antibacterial, antioxidant and anti-cancer properties. Herein, we studied the use of dual-probe ultrasound to extract triterpenoids from GLSP and further investigated the bioactivity of resulting products. FTIR results confirm the presence of key peaks although dual-probe ultrasound varied extraction efficacy. Response surface methodology (RSM) was used to optimize extraction conditions (55:28 for solvent to solid ratio, 10.38 s of ultrasound time and 94% v/v of ethanol concentration). HPLC-Q-TOF-MS confirmed the presence of nine different compounds and <i>in vitro</i> tests confirm good biocompatibility. Extracts are shown to inhibit DPPH radicals, reaching a maximum (61.09 ± 1.38%) at triterpenoid concentrations of 600 µg/mL. Dual-mode assisted extraction provides an enhanced approach for active embedded fiber production on a scale favorable to industry when using optimized process parameters. Furthermore, triterpenoid extracts show antibacterial properties on <i>Staphylococcus aureus</i> and <i>Escherichia coli</i> with potential in antibacterial and anticancer applications.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?